Clincosm LogoSign in Get a demo

atherosclerotic cardiovascular disease

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Atherosclerotic Cardiovascular Disease Trial (YN001, Placebo for YN001, rosuvastatin calcium tablets)

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • (no location specified)
    Sep 21, 2023

    ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

    Not yet recruiting
    • ASCVD
    • +3 more
    • (no location specified)
    Aug 3, 2023

    Atherosclerotic Cardiovascular Disease Trial (Notification of CAC, Usual Care)

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • Notification of CAC
    • Usual Care
    • (no location specified)
    Jul 28, 2023

    Inclisiran on Major Adverse Cardiovascular Events in French

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium
    • +3 more
    • (no location specified)
    Jul 26, 2023

    Apical Periodontitis and Atherosclerotic Cardiovascular Diseases

    Recruiting
    • Apical Periodontitis
    • Atherosclerotic Cardiovascular Disease
    • Echo-color-doppler
    • Siena, Italy
      Azienda Ospedaliera Universitaria Senese
    Mar 19, 2023

    Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
    • Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
    • Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
    • (no location specified)
    Mar 14, 2023

    Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • Atozet 10/40 mg or 10/80 mg
    • Lipitor 40 mg or 80 mg
    • (no location specified)
    Mar 8, 2023

    The Belgian REAL (BE.REAL) Registry

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • Inclisiran
    • (no location specified)
    Feb 3, 2023

    Atherosclerotic Cardiovascular Disease Trial in Philadelphia (Outreach + Bulk ordering, Outreach + Bulk ordering + Text Based

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • Outreach + Bulk ordering
    • Outreach + Bulk ordering + Text Based Reminders and Scheduling assistance
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 9, 2023

    Immunomodulatory Effects of PCSK9 Inhibition

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +3 more
    • Contrast-enhanced CCTA
    • 99mTc-tilmanocept SPECT/CT scanning
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 30, 2023

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Lp(a) Screening)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Lp(a) Screening
    • Birmingham, Alabama
    • +670 more
    Feb 1, 2023

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Huntsville, Alabama
    • +83 more
    Feb 1, 2023

    Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)

    Not yet recruiting
    • Dyslipidemias
    • Atherosclerotic Cardiovascular Disease
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jan 29, 2023

    Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

    Active, not recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
    • Sale, Cheshire, United Kingdom
    • +16 more
    Jan 20, 2023

    Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Little Rock, Arkansas
    • +43 more
    Jan 20, 2023

    Healthy Volunteers, Atherosclerotic Cardiovascular Disease Trial in Fukuoka (NNC0385-0434, Placebo)

    Completed
    • Healthy Volunteers
    • Atherosclerotic Cardiovascular Disease
    • Fukuoka, Japan
      Novo Nordisk Investigational Site
    Jan 17, 2023

    Atherosclerotic Cardiovascular Disease, STEMI, Non STEMI Trial in Netherlands

    Enrolling by invitation
    • Atherosclerotic Cardiovascular Disease
    • +2 more
      • Alkmaar, Netherlands
      • +12 more
      Dec 12, 2022

      Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Placebo, Obicetrapib)

      Recruiting
      • Dyslipidemias
      • +4 more
      • Anniston, Alabama
      • +126 more
      Dec 8, 2022

      Qualitative Features of Atherosclerotic Plaques

      Active, not recruiting
      • Atherosclerotic Cardiovascular Disease
      • Riga, Latvia
        Pauls Stradins Clinical University Hospital
      Dec 5, 2022

      Time Restricted Feeding, Myocardial Infarction, Atherosclerotic Cardiovascular Disease Trial in Nijmegen (Time restricted eating

      Recruiting
      • Time Restricted Feeding
      • +2 more
      • Time restricted eating (TRE)
      • Regular diet
      • Nijmegen, Gelderland, Netherlands
        Radboud university medical center
      Dec 5, 2022

      Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman

      Not yet recruiting
      • Dyslipidemias
      • Atherosclerotic Cardiovascular Disease
        • Amman, Jordan
        • +1 more
        Nov 23, 2022

        Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

        Active, not recruiting
        • Hypertriglyceridemia
        • +2 more
        • Lincoln, California
        • +23 more
        Nov 23, 2022

        Coronary Artery Disease, Myocardial Infarction, Angina, Unstable Trial in Nablus (Compressive Elastic dressing for hemostasis in

        Completed
        • Coronary Artery Disease
        • +10 more
        • Compressive Elastic dressing for hemostasis in cardiac procedure using radial approach
        • Wristband TR band for hemostasis in cardiac procedure using radial approach
        • Nablus, West Bank, Palestinian Territory, occupied
        • +1 more
        Sep 27, 2022

        Precision Treatment With Angiotensin Converting Enzyme Inhibitor

        Recruiting
        • Hypertension
        • +2 more
          • Seoul, Korea, Republic of
            Yonsei University Health System, Severance Hospital
          Sep 7, 2022